Skip to content

Clinical epidemiological study of repetitive transcranial magnetic stimulation in the treatment of autism spectrum disorder

Clinical epidemiological study of repetitive transcranial magnetic stimulation in the treatment of autism spectrum disorder

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500103397
Enrollment
Unknown
Registered
2025-05-28
Start date
2025-06-09
Completion date
Unknown
Last updated
2025-06-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Autism Spectrum Disorder,ASD

Interventions

ABA treatment control group:applied behavior analysis,ABA
rTMS treatment group:rTMS
rTMS placebo control group:Repetitive transcranial magnetic pseudo-stimulation
Blank control group:None

Sponsors

Peking University Sixth Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
4 Years to 12 Years

Inclusion criteria

Inclusion criteria: 1.Age range: 4 to 12 years old; 2.Meet the diagnostic criteria for autism spectrum disorder in DSM-5; 3.Be able to complete the treatment as required within the research period; 4.The patient or the parents agree to sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1.Suffer from a serious physical illness; 2.Suffer from mental disorders such as attention deficit hyperactivity disorder, bipolar disorder, schizophrenia, and mental retardation; 3.Suffer from neurological diseases such as epilepsy.

Design outcomes

Primary

MeasureTime frame
Score of Childhood Autism Rating Scale (CARS);

Secondary

MeasureTime frame
Electroencephalogram detection;Non-targeted blood metabolomics;Plasma arginine vasopressin;Plasma oxytocin;Red blood cell trace elements, macronutrients, rare earth elements (more than 40 kinds);Plasma or saliva oxidative stress series, including nitrate, nitrite, plasma iron reduction capacity (FRAP), malondialdehyde (MDA), free radical scavenging capacity (ABTS), reduced glutathione (GSH),;

Countries

China

Contacts

Public ContactYueqin Huang

Peking University Sixth Hospital

dengy@mail.tsinghua.edu.cn+86 10 82802836

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026